Mithra Women's Health presenting good news at CPHI conference

October 11, 2018 News BioVox

11 October 2018

Mithra (Euronext Brussels: MITRA), a Liège-based company dedicated to Women’s Health, provided an update on its key programmes at the CPHI world conference held yesterday. News was very positive, with the company reporting strong clinical and financial results.

2018 UPDATE AND 2019 OUTLOOK GIVEN AT THE CPHI CONFERENCE:

  • Estelle® Oral Contraception programme on track – US/CANADA Phase III arm due to complete in Q4 2018; partnering discussions ongoing including for US market
  • Preparations for Phase III Donesta® trials moving ahead, including co-partnering discussions
  • Further Marketing authorisations obtained for MyRing™
  • Continuously improved IP portfolio
  • Strenghtened cash position

Read the full press release here.


Avatar photo
BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

All posts

Subscribe to the BioVox newsletter